Related Experiment Video
Updated: Apr 11, 2026

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
Published on: December 9, 2022
Management of pseudomyxoma peritonei
Simon A Fallis1, Brendan J Moran
1Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Aldermaston Road, Basingstoke, United Kingdom.
Pseudomyxoma peritonei (PMP) is a rare condition from appendix neoplasms, causing mucinous ascites. Optimal treatment with cytoreductive surgery and HIPEC offers significant survival benefits for low-grade disease.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Pathology
Background:
- Pseudomyxoma peritonei (PMP) is an uncommon condition originating from appendiceal neoplasms.
- Characterized by mucinous ascites and peritoneal tumor cell accumulation.
- Considered a borderline malignancy with variable presentation and non-specific symptoms.
Purpose of the Study:
- To review the clinical presentation, pathology, staging, and treatment of Pseudomyxoma Peritonei.
- To highlight the role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Main Methods:
- Review of computed tomography (CT) for preoperative staging.
- Analysis of serum tumor markers for prognostic value.
- Evaluation of cytoreductive surgery and HIPEC as primary treatment modality.
Main Results:
- Complete cytoreduction with HIPEC achieves an 80% 5-year survival in low-grade PMP.
- Maximal tumor debulking can offer palliation and long-term survival.
- Improved outcomes are linked to enhanced patient selection, postoperative care, and surgical expertise.
Conclusions:
- PMP represents a spectrum of disease requiring careful pathological classification and staging.
- Cytoreductive surgery with HIPEC is the optimal treatment for PMP.
- Surgical expertise and improved management strategies are reducing morbidity and mortality.
Related Concept Videos
Pericarditis III: Medical Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peritoneal Dialysis III: Nursing Management

